MIF and diabetes mellitus: Furthermore, the occurrence of MIF inhibitors in cruciferous vegetables as a natural product [74] suggests that MIF will be more a promising therapeutic target in the future. On the other hand, SCD1 inhibitors have been developed as drugs for diabetes and dyslipidemia [75].